Device and method for determining tissue thickness and creating cardiac ablation lesions

Information

  • Patent Grant
  • 8333764
  • Patent Number
    8,333,764
  • Date Filed
    Wednesday, May 12, 2004
    20 years ago
  • Date Issued
    Tuesday, December 18, 2012
    12 years ago
Abstract
A tissue ablation device has a handle and an ablation head coupled to the handle. The ablation head has a first jaw, a second jaw, and an ablative element coupled to at least one of the first and second jaws. A thickness measurement device may be coupled to the ablation device to indicate the distance separating the first and second jaws. Further, a force measurement device may be coupled to the ablation device to measure the force being applied by the first and second jaws to a piece of tissue. Further, a strain measurement device may be coupled to the ablation device to indicate the strain resulting in a piece of tissue disposed between the first and second jaws when a stress is applied to the tissue.
Description
FIELD OF THE INVENTION

The present invention relates to tissue ablation devices generally, and more particularly to devices adapted to ablate lines of tissue, for example for use in conjunction with an electrosurgical version of the Maze procedure. More particularly, the invention relates to an ablation device that aids in the measurement of tissue thickness and monitoring the transmurality of lesions.


BACKGROUND OF THE INVENTION

Various types of electrophysiology devices are used for ablating tissue. Typically, such devices include a conductive tip or blade which serves as one electrode in an electrical circuit which is completed via a grounding electrode coupled to the patient. With sufficiently high levels of electrical energy between the two electrodes, heat is generated which is sufficient to denature proteins within the tissue and cause cell death.


It is well known that by controlling the energy level, the amount of heat generated and degree of tissue damage can also be controlled. High levels of voltage can cut and remove tissue (i.e. electrosurgery), while lower levels will simply create sufficient heat to cause cell damage, but leave the structure intact and block electrical pathways within the tissue. Irrigation of the electrodes with saline or other conductive fluid can decrease the interface impedance, cool the tissue, and allow for a greater lesion depth. It is also know that a bipolar system (where the grounding electrode is in close proximity to the conductive tip) can create narrower and deeper lesions. At the limit, the grounding electrode is in the same dimension as the conductive tip, and both electrodes are used to create the lesion.


A bipolar ablation design may be created by integrating the electrode into the jaws of a hemostat (or forceps) like device. Mounting two electrodes onto the jaws of a forceps results in a tool that can clamp and ablate the tissue between the jaws.


A wide variety of surgical procedures involve ablation of selected tissue. One such procedure is the Maze procedure, which is a surgical operation for patients with atrial fibrillation that is resistant to medical treatment. In the conventional version of this procedure, incisions are created in the right and left atria to produce an orderly passage of the electrical impulse from the sino-atrial node (SA node) to the atrial-ventricular node (AV node). Blind passageways are also created to suppress reentry cycles. Ablation of cardiac conduction pathways in the region of tissue where electrical signals are malfunctioning is now being used to replace surgical incisions in the Maze procedure. Ablation is also used therapeutically with other organ tissues, such as the lungs, liver, prostate, and uterus. Ablation may also be used in treatment of disorders, such as tumors, cancers, or undesirable growths. There are various types of ablation devices that are in use and in development that are intended for use in the Maze procedure.


Sometimes ablation is necessary only at discrete positions along the tissue. At other times, ablation is desired along a line, called linear ablation. This is the case for atrial fibrillation, where the aim is to reduce the total mass of contiguous (electrically connected) atrial tissue below a threshold believed to be critical for sustaining multiple reentrant wavelets. Linear lesions are created between electrically non-conductive anatomic landmarks to reduce the contiguous atrial mass. One way of accomplishing linear ablation is to use a pair of bipolar electrosurgical forceps having jaws with an elongated electrode or series of electrodes used to apply energy to tissue for ablation purposes. One embodiment of this approach is described in U.S. patent Publication No. 2003/0171745, published Sep. 11, 2003, and titled “Ablation System and Method of Use,” which is incorporated herein by reference in its entirety.


In conjunction with the use of electrosurgical ablation devices, various control mechanisms have been developed to control delivery of ablation energy to achieve the desired result of ablation (killing of cells at the ablation site while leaving the basic structure of the organ to be ablated intact). Additionally, there has been substantial work done toward assuring that the ablation procedure is complete, i.e. that the ablation extends through the thickness of the tissue to be ablated, before terminating application of ablation energy. This desired result is referred to as “transmural” ablation. Non-transmural lesions may be capable of propagating a depolarization wave form, or action potential and may not be effective in treating an arrhythmia. One embodiment of a system for assessing the transmurality of an ablation lesion is described in U.S. patent Publication No. 2003/0195384, published Oct. 16, 2003, and titled “System and Method for Assessing Transmurality of Ablation Lesions,” which is incorporated herein by reference in its entirety.


One challenge associated with ablation procedures relates to determining the proper energy to apply to the tissue and duration of application of that energy in order to achieve the desired transmurality. One approach is to estimate tissue thickness and then to consult a look-up table to determine an experimentally determined energy and duration associated with that thickness. However, such an approach requires an accurate assessment of tissue thickness, which may also present a challenge. Further, depending on the type of device used to apply ablation energy to the tissue, further variables may be introduced. For example, when using a hemostat type device, the pressure between the jaws is a function of the force applied to the handles any may vary depending on the person holding the device. Such variability impacts the most effective treatment time and energy.


The design challenge with any ablation device, and in particular with a hemostat type device, is to create a lesion having consistent quality, in particular a continuous linear lesion when engaging in the Maze procedure. Further, it is desirable to create a lesion that is not too wide and that may be created in the least amount of time. Further, a challenge in the creation of such a device is to reduce the variability based upon the user such that a device may be used by various users with consistent results.


Accordingly, there is a need for an ablation device that is configured to permit a consistent application of appropriate force at the tissue site when in use. Further, there is a need for a device configured to permit real time assessment of lesion transmurality while in use. Further still, there is a need for an ablation device having the ability to aid in the determination of ablation parameters, such as degree of applied force, time of treatment, and treatment energy.


It would be desirable to provide a system and/or method that provides one or more of these or other advantageous features. Other features and advantages will be made apparent from the present specification. The teachings disclosed herein extend to those embodiments that fall within the scope of the appended claims, regardless of whether they accomplish one or more of the aforementioned needs.


SUMMARY OF THE INVENTION

The invention relates to a tissue ablation system having a handle and an ablation head coupled to the handle. The ablation head has a first jaw and a second jaw and an ablative element coupled to at least one of the first and second jaws. A thickness measurement device is coupled to the ablation head. The thickness measurement device indicates a distance separating the first and second jaws.


The invention further relates to a tissue ablation system having a handle and an ablation head coupled to the handle. The ablation head has a first jaw and a second jaw and an ablative element coupled to at least one of the first and second jaws. A force measurement device is coupled to the ablation head. The force measurement device indicates the force being applied by the first and second jaws on a piece of tissue disposed between the first and second jaws.


The invention further relates to a tissue ablation system having a handle and an ablation head coupled to the handle. The ablation head has a first jaw and a second jaw and an ablative element coupled to at least one of the first and second jaws. A strain measurement device is coupled to the ablation head. The strain measurement device indicates the strain resulting in a piece of tissue disposed between the first and second jaws when a stress is applied to the tissue.


The invention further relates to a method of assessing the transmurality of an ablation lesion in a piece of tissue during the performance of a surgical ablation procedure. The method includes the steps of applying a stress to the piece of tissue and calculating a strain in the tissue resulting from the application of the stress. The method further includes the step of determining the degree of transmurality of the ablation lesion based upon the strain and the stress.


The invention further relates to a method of ablating tissue. The method includes the steps of providing a bipolar ablation device having a pair of jaws, the jaws having one or more ablation electrodes, inserting the tissue between the jaws, and closing the jaws until the jaws engage the tissue. The method further includes the steps of measuring a thickness of the tissue by determining the distance between the jaws, selecting a jaw force, selecting an electrode energy, and selecting a time of energy application. The method further includes the steps of applying the selected jaw force to the tissue, energizing the one or more ablation electrodes to apply the selected electrode energy, and deenergizing the one or more ablation electrodes after the selected time has elapsed.


The invention is capable of other embodiments and of being practiced or carried out in various ways. Alternative exemplary embodiments relate to other features and combinations of features as may be generally recited in the claims.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention will become more fully understood from the following detailed description, taken in conjunction with the accompanying drawings, wherein like reference numerals refer to like elements, in which:



FIG. 1 is a schematic perspective view of a tissue ablation system;



FIG. 2 is a perspective view of the head of a bipolar tissue ablation device having a thickness gauge;



FIG. 3 is a perspective view of the head of a bipolar tissue ablation device having a force meter;



FIG. 4 is a perspective view of the head of a bipolar ablation device having a strain gauge integrated therein;



FIG. 5 is an elevation view of the head of a bipolar ablation device engaging a piece of tissue; and



FIG. 6 is a chart showing exemplary stress versus strain curves for tissues in various states of ablation.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

Referring to FIG. 1, a tissue ablation device, shown as a bipolar ablation device 10 has a handle 12 and an ablation head 14. A trigger 16 may be used by a surgeon to control certain functions of the ablation head 14. A switch, shown as locking mechanism 18, may be utilized to lock the ablation head 14 into position during a surgical procedure.


Further referring to FIG. 1, in an exemplary embodiment of a tissue ablation system, bipolar ablation device 10 may be partially controlled by and may provide feedback to a control device, such as generator 22. A cord 20 serves as a conduit for various smaller cords and tubes between generator 22 and ablation device 10. For example, cord 20 may house a power line for ablation head 14, saline irrigation lines to and from ablation head 14, and various other wires and cords sending signals to and receiving signals from ablation head 14. An exemplary bipolar ablation device having many of the features described with respect to FIG. 1 is the CARDIOBLATE BP™ brand ablation system, available from Medtronic, Inc.


Referring to FIG. 2, in an exemplary embodiment, ablation head 14 has a pair of jaws 24, 26. One or both of the jaws 24, 26 may have an ablative element for ablating tissue. The ablative element is typically an energy transfer device. In the embodiment shown in FIG. 2, ablative elements are shown as linear electrodes 28, that are used to impart RF energy to tissue for ablation purposes. There are many types of ablative elements and electrodes that may be used for ablation purposes, some of which are described in U.S. patent Publication No. 2003/0171745.


Further referring to FIG. 2, one jaw 24 may be pivotally coupled to the other jaw 26 via a pivot point 32 so that the jaws 24, 26 may be opened and closed via a mechanical or electromechanical mechanism known in the art. Further, jaw 26 is shown as being rotatably coupled to a base 34 via a pivot point 30, allowing jaws 24, 26 to be rotated together with respect to base 34. Base 34 is coupled to handle 12 and may have a mechanism allowing for quick removal from handle 12. In an exemplary embodiment, jaws 24, 26 are approximately seven centimeters in length and the electrodes 28 are each approximately five centimeters in length. Jaws 24, 26 may have length markings 36 to aid in their performance of surgical procedures. Further, jaws 24, 26 may be malleable such that a surgeon may curve the jaws to conform to a desired ablation lesion shape.


Further referring to FIG. 2, a thickness measurement device shown as thickness gauge 40 may be coupled to ablation head 14 in an exemplary embodiment. The thickness gauge 40 is used to determine the thickness of material placed between jaws 24, 26. One such way of determining the thickness of material between jaws 24, 26 is for thickness gauge 40 to be a potentiometer or rheostat coupled to the ablation head 14 at pivot point 32. Such a potentiometer may provide an electronic output signal representative of the distance between jaws 24, 26, the signal changing as upper jaw 24 is rotated with respect to lower jaw 26. In an exemplary embodiment, the signal provided by the potentiometer may be converted by the generator 22 (see FIG. 1) into a reading representative of the distance between jaws 24, 26, indicating the thickness of a piece of tissue between jaws 24, 26. The reading may be shown on a display 23 (see FIG. 1).


Although thickness gauge 40 is shown as a potentiometer or rheostat in FIG. 2, other thickness measurement devices may also be used, such as an ultrasonic thickness gauge or markings on the head 14 providing a visual indication of the distance between jaws 24, 26. Alternatively, receiver/transmitter pairs may be inserted into the jaws that electronically measure the distance between the electrodes and therefore the thickness of tissue between the jaws. In the embodiment depicted in FIG. 2, the jaws are pivotally coupled to one another so the distance between the jaws may be related to the angle between the jaws. However, in other systems where the jaws are adjusted in a linear fashion, thus maintaining the electrodes parallel with one another, the measured distance may be in units of length. Even when the measurement is made in degrees, the number of degrees may be converted to a reading in units of length, such as to provide the distance between the midpoints of each of the jaws 24, 26.


Referring to FIG. 3, in an exemplary embodiment, a force measurement device, shown as force meter 50 is incorporated into ablation head 14. The force meter 50 provides a measurement of the force being applied between jaws 24, 26 on material, such as tissue placed between jaws 24, 26. Various types of force meters used to provide an indication of the force between a pair of jaws are known in the mechanical arts.


The force meter 50 may provide a direct indication of the force being applied between the electrodes 28 or may alternatively provide an electronic signal representative of the force to another instrument, such as generator 22, which may then convert the electronic signal into a reading representative of the force being applied. In one embodiment, the jaws 24, 26 are closed by depressing trigger 16 (see FIG. 1). In such a case, a user may apply a certain amount of force to trigger 16 resulting in an appropriate force between jaws 24, 26 as indicated by force meter 50. The user may then lock the jaws 24, 26 into place with locking mechanism 18 prior to energizing linear electrodes 28. Alternatively, a user may program an appropriate jaw force into generator 22, for example, which may automatically close jaws 24, 26 over a desired piece of tissue and apply the desired amount of force, without the user having to depress trigger 16. While the force meter 50 is shown as being attached to base 34, it is to be understood that a force measurement device providing the desired functionality of force meter 50 may be placed in several different locations on bipolar ablation device, depending on the method by which the force between jaws 24, 26 is measured.


Referring to FIG. 4, in an exemplary embodiment, a strain measurement device, shown as strain gauge 60, may be incorporated into bipolar ablation device 10. The strain gauge 60 may be used to determine the amount of strain resulting in a material between jaws 24, 26 due to an applied stress. Various types of strain gauges are known in the art. The strain in the material between jaws 24, 26 may be calculated by any of a number of methods, such as by calculating the ratio of the distance of compaction of the material between jaws 24, 26 and the original thickness of the material between jaws 24, 26. The strain gauge 60 may automatically calculate the strain, or the strain may be calculated by an external instrument, such as generator 22, utilizing inputs provided by the strain gage 60 or other devices in the head 14, such as the thickness gauge 40. The output from strain gauge 60 may be utilized in other calculations as discussed below.


Referring to FIG. 5, in the performance of certain surgical procedures, such as a Maze procedure, the bipolar ablation device is used to create ablation lesions in tissue, such as heart tissue. In the performance of such a procedure utilizing bipolar ablation device, jaws 24, 26 are placed over a selected portion of tissue 70. An electrode energy is then selected along with a desired degree of force to be applied to tissue 70 between jaws 24, 26. Further, an ablation time may be selected that corresponds to the thickness of tissue 70 and the force being applied between jaws 24, 26.


In order to access the tissue to be ablated, a surgeon must first open an aperture into a patient's body. In the performance of a Maze procedure, access to the patient's heart may be provided via an open chest, such as utilizing a median sternotomy. Alternatively, access to the heart may be provided via a minimally invasive approach, such as with endoscopic tools on a “closed” chest, using one or more small incisions or ports. The Maze procedure may be performed on a beating heart, or on a stopped heart, requiring the use of a heart lung machine to place the patient on cardiopulmonary bypass. The locations of the lesions made in the performance of a Maze procedure, as well as methods of accessing the heart, are known in the art.


In order to create a lesion, the surgeon inserts a selected portion of tissue 70 between jaws 24, 26 and closes the jaws on the tissue 70 using an appropriate amount of force. The jaws may be closed utilizing the trigger 16 (see FIG. 1) or may be done automatically from signals sent from generator 22 or other control device.


Prior to selecting the ablation parameters such as RF energy, force, and time, the surgeon may wish to know the tissue thickness. The thickness gauge 40 may be utilized to provide the thickness parameter by closing the jaws 24, 26 over the selected portion of tissue 70 and providing a visual indication of or signal representative of the thickness of tissue 70.


After determining the thickness of tissue 70, the surgeon may apply an appropriate amount of force using jaws 24, 26 prior to engaging electrodes 28. In order to provide accuracy in the amount of force applied, the force meter 50 of the present invention may be utilized to measure the force being applied. The amount of force may be visually read by the surgeon or may be provided in an electronic signal representative of the force to a control unit such as generator 22.


After closing the jaws 24, 26 on tissue 70 at the appropriate degree of force, the surgeon may lock the jaws into place at that degree of force utilizing locking mechanism 18. Alternatively, robotic control of the jaws may be provided by a control device, such as generator 22, rather than a manual locking mechanism 18. At this point, the surgeon may engage linear electrodes 28 to begin the creation of an ablation lesion in tissue 70. During the application of RF energy to create the ablation lesion, saline may be applied to the ablation area between electrodes 28 to cool the tissue 70. Saline may be provided to jaws 24, 26 via a saline irrigation line connected to a saline source.


Once an RF energy and force of application have been selected and the tissue thickness has been determined, a surgeon may determine the time of energy application necessary to accomplish the goal of a transmural lesion. The time may be selected from experimental results for a particular type of tissue. Particularly when performing a Maze procedure, it is desirable to select the proper amount of time to ensure lesion transmurality, as a non-transmural ablation may not accomplish the goal of the procedure, and applying energy for too much time may damage the tissue more than necessary. Once the time of energy application has been determined, the surgeon may activate the electrodes 28 to ablate the tissue 70 between jaws 24, 26. After a transmural lesion has been created, the surgeon opens the jaws 24, 26 and repositions the bipolar ablation device to another region of tissue or removes the device from the patient's body and completes the procedure.


Although a precise tissue thickness measurement and application of force aids in accurately determining the amount of time necessary to create a transmural lesion, it may be beneficial to provide an indicator of lesion transmurality to ensure success of the procedure. Visual assessment of the tissue to determine transmurality may be inconvenient or impossible depending on the location of the tissue being ablated and the type of ablation device. Methods of assessing the transmurality of ablation lesions have been disclosed, such as the temperature assessment method disclosed in U.S. patent Publication No. 2003/0195384.


According to one embodiment of the invention, the bipolar ablation device 10 provides a method of assessing lesion transmurality. The method may be utilized while the electrodes are energized to provide a real time assessment of lesion transmurality or may be utilized after electrodes have been utilized to create a lesion, to ensure the proper depth of ablation. It is known that ablated tissue exhibits a different strain for a given amount of stress than does non-ablated tissue. Referring to FIG. 6, hypothetical stress versus strain curves are shown to indicate the difference in strain for a given application of stress for ablated and non-ablated tissues. For example, curve 72 may correspond to fully ablated tissue in which complete transmurality has been achieved, curve 74 may correspond to partially ablated tissue, and curve 76 may correspond to non-ablated tissue.


As described above, certain embodiments of the present invention are described as having a strain measurement device, such as strain gauge 60, and a force measurement device such as force meter 50. These elements may be combined to provide the information necessary to utilize stress versus strain data to determine lesion transmurality. A given amount of stress may be applied to the tissue utilizing force meter 50 as an indicator of the force being applied over the area of the jaws. Alternatively, the selected amount of stress may be applied automatically using a control device such as generator 22. The resultant strain may be directly measured using strain gauge 60, but may also be calculated using thickness gauge 40 to calculate the change in thickness resultant from the applied stress versus the original thickness of the tissue.


The strain measurement may be quickly performed during a procedure while the electrodes are activated if desired. If this is the case, a control device, such as generator 22, may be programmed to perform real time assessments of lesion transmurality and automatically cease the application of RF energy through electrodes 28 when lesion transmurality has been accomplished. Further, stress versus strain curves for a number of degrees of lesion transmurality may be generated and programmed into generator 22 such that the user may be provided a real time indication of depth of ablation as a procedure is being performed.


While the concepts of measuring tissue thickness, force application, and tissue strain are described with respect to a bipolar ablation device, such concepts may be useful when applied to other types of ablation devices such as an electrocautery device, an electrosurgical device, an ablation paddle, and an ablation wire, among other types of devices. A set up similar to that shown in FIGS. 1-5 may be utilized, for example by replacing the ablation head 14 with a different type of ablation device. Further, ablation may be accomplished using ultrasonic energy, microwave energy, or a cryogenic approach, instead of or in addition to the RF energy described herein.


The bipolar ablation device and system may be used in procedures requiring tissue ablation in the heart as described herein. However, the ablation device and system may also be used on other tissues (e.g. lungs, liver, prostate, etc.) and in other types of surgical procedures that require tissue ablation.


The generator depicted in FIG. 1 may be used to provide power to bipolar ablation device 10 and to control the various parts that are subject to automatic control, such as the opening, closing, and positioning of ablation head 14 and jaws 24, 26. The generator may have various visual displays, such as the force being applied, the thickness of a selected piece of tissue, and the degree of lesion transmurality (such as percentage complete). The generator may also incorporate other functions associated with surgical procedures, such as functioning as a cardiac monitor.


While the detailed drawings and specific examples given herein describe various exemplary embodiments, they serve the purpose of illustration only. It is to be understood that the invention is not limited in its application to the details of construction and the arrangements of components set forth in the preceding description or illustrated in the drawings. For example, in various embodiments described in this application, a force measurement device, a thickness measurement device, and a strain measurement device are described. These may be used separately on devices, or in various combinations as desired. Furthermore, other substitutions, modifications, changes, and omissions may be made in the design, operating conditions, and arrangements of the exemplary embodiments without departing from the scope of the invention as expressed in the appended claims.

Claims
  • 1. A tissue ablation system comprising: a handle;an ablation head coupled to the handle, the ablation head having a first jaw and a second jaw adapted to apply a force on tissue disposed between the first and second jaws;an ablative element coupled to at least one of the first and second jaws for delivering an ablative energy to tissue disposed between the first and second jaws;a thickness measurement device coupled to the ablation head, wherein the thickness measurement device outputs an electrical signal that indicates a distance separating the first and second jaws; anda generator electrically coupled to the ablation head, wherein the generator controllably delivers RF ablative energy to the ablative element to form a transmural ablation lesion in tissue disposed between the first and second jaws for an ablation time period that is determined based on at least the electrical signal outputted from the thickness measurement device and that is electrically provided to the generator; andthe generator having a display and wherein the distance separating the first and second jaws is shown on the display.
  • 2. The tissue ablation system of claim 1, wherein the thickness measurement device is a thickness gauge.
  • 3. The tissue ablation system of claim 2, wherein the thickness gauge is a potentiometer.
US Referenced Citations (406)
Number Name Date Kind
3736936 Basiulis et al. Jun 1973 A
3807403 Stumpf et al. Apr 1974 A
3823575 Parel Jul 1974 A
3823718 Tromovitch Jul 1974 A
3827436 Stumpf et al. Aug 1974 A
3830239 Stumpf Aug 1974 A
3859986 Okada et al. Jan 1975 A
3862627 Hans, Sr. Jan 1975 A
3886945 Stumpf et al. Jun 1975 A
3907339 Stumpf et al. Sep 1975 A
3910277 Zimmer Oct 1975 A
3913581 Ritson et al. Oct 1975 A
3924628 Droegemueller et al. Dec 1975 A
4018227 Wallach Apr 1977 A
4022215 Benson May 1977 A
4061135 Widran et al. Dec 1977 A
4063560 Thomas et al. Dec 1977 A
4072152 Linehan Feb 1978 A
4082096 Benson Apr 1978 A
4207897 Lloyd et al. Jun 1980 A
4248224 Jones Feb 1981 A
4275734 Mitchiner Jun 1981 A
4278090 van Gerven Jul 1981 A
4377168 Rzasa et al. Mar 1983 A
4519389 Gudkin et al. May 1985 A
4598698 Siegmund Jul 1986 A
4601290 Effron et al. Jul 1986 A
4664110 Schanzlin May 1987 A
4736749 Lundback Apr 1988 A
4779611 Grooters et al. Oct 1988 A
4802475 Weshahy Feb 1989 A
4815470 Curtis et al. Mar 1989 A
4872346 Kelly-Fry et al. Oct 1989 A
4916922 Mullens Apr 1990 A
4917095 Fry et al. Apr 1990 A
4936281 Stasz Jun 1990 A
4946460 Merry et al. Aug 1990 A
5013312 Parins et al. May 1991 A
5029574 Shimamura et al. Jul 1991 A
5044165 Linner et al. Sep 1991 A
5078713 Varney Jan 1992 A
5080102 Dory Jan 1992 A
5080660 Buelna Jan 1992 A
5100388 Behl et al. Mar 1992 A
5108390 Potocky et al. Apr 1992 A
5147355 Friedman et al. Sep 1992 A
5178133 Pena Jan 1993 A
5207674 Hamilton May 1993 A
5217860 Fahy et al. Jun 1993 A
5222501 Ideker et al. Jun 1993 A
5224943 Goddard Jul 1993 A
5228923 Hed Jul 1993 A
5231995 Desai Aug 1993 A
5232516 Hed Aug 1993 A
5254116 Baust et al. Oct 1993 A
5263493 Avitall Nov 1993 A
5269291 Carter Dec 1993 A
5275595 Dobak, III Jan 1994 A
5277201 Stern Jan 1994 A
5281213 Milder et al. Jan 1994 A
5281215 Milder Jan 1994 A
5295484 Marcus et al. Mar 1994 A
5300068 Rosar et al. Apr 1994 A
5309896 Moll et al. May 1994 A
5316000 Chapelon et al. May 1994 A
5317878 Bradshaw et al. Jun 1994 A
5318525 West et al. Jun 1994 A
5322520 Milder Jun 1994 A
5323781 Ideker et al. Jun 1994 A
5324255 Passafaro et al. Jun 1994 A
5324284 Imran Jun 1994 A
5324286 Fowler Jun 1994 A
5334181 Rubinsky et al. Aug 1994 A
5334193 Nardella Aug 1994 A
5342357 Nardella Aug 1994 A
5348554 Imran et al. Sep 1994 A
5353783 Nakao et al. Oct 1994 A
5354258 Dory Oct 1994 A
5361752 Moll et al. Nov 1994 A
5385148 Lesh et al. Jan 1995 A
5395033 Byrne et al. Mar 1995 A
5396887 Imran Mar 1995 A
5397304 Truckai Mar 1995 A
5400770 Nakao et al. Mar 1995 A
5400783 Pomeranz et al. Mar 1995 A
5403309 Coleman et al. Apr 1995 A
5403311 Abele et al. Apr 1995 A
5405376 Mulier et al. Apr 1995 A
5409483 Campbell et al. Apr 1995 A
5423807 Milder Jun 1995 A
5423811 Imran et al. Jun 1995 A
5427119 Swartz et al. Jun 1995 A
5431645 Smith et al. Jul 1995 A
5431649 Mulier et al. Jul 1995 A
5433708 Nichols et al. Jul 1995 A
5435308 Gallup et al. Jul 1995 A
5437651 Todd et al. Aug 1995 A
5437664 Cohen et al. Aug 1995 A
5443463 Stern et al. Aug 1995 A
5443470 Stern et al. Aug 1995 A
5450843 Moll et al. Sep 1995 A
5452582 Longsworth Sep 1995 A
5452733 Sterman et al. Sep 1995 A
5456682 Edwards et al. Oct 1995 A
5462545 Wang et al. Oct 1995 A
5465717 Imran et al. Nov 1995 A
5469853 Law et al. Nov 1995 A
5472876 Fahy Dec 1995 A
5478309 Sweezer et al. Dec 1995 A
5478330 Imran et al. Dec 1995 A
5486193 Bourne et al. Jan 1996 A
5487385 Avitall Jan 1996 A
5487757 Truckai et al. Jan 1996 A
5496312 Klicek Mar 1996 A
5497774 Swartz et al. Mar 1996 A
5498248 Milder Mar 1996 A
5500012 Brucker et al. Mar 1996 A
5505730 Edwards Apr 1996 A
5516505 McDow May 1996 A
5520682 Baust et al. May 1996 A
5522870 Ben-Zion Jun 1996 A
5536267 Edwards et al. Jul 1996 A
5542928 Evans et al. Aug 1996 A
5545195 Lennox et al. Aug 1996 A
5545200 West et al. Aug 1996 A
5549661 Kordis et al. Aug 1996 A
5555883 Avitall Sep 1996 A
5558671 Yates Sep 1996 A
5560362 Sliwa, Jr. et al. Oct 1996 A
5562720 Stern et al. Oct 1996 A
5569241 Edwards Oct 1996 A
5571088 Lennox et al. Nov 1996 A
5571215 Sterman et al. Nov 1996 A
5573532 Chang et al. Nov 1996 A
5575766 Swartz et al. Nov 1996 A
5575788 Baker et al. Nov 1996 A
5575810 Swanson et al. Nov 1996 A
5578007 Imran Nov 1996 A
5582609 Swanson et al. Dec 1996 A
5584872 LaFontaine et al. Dec 1996 A
5588432 Crowley Dec 1996 A
5590657 Cain et al. Jan 1997 A
5595183 Swanson et al. Jan 1997 A
5607462 Imran Mar 1997 A
5609151 Mulier et al. Mar 1997 A
5617854 Munsif Apr 1997 A
5630837 Crowley May 1997 A
5637090 McGee et al. Jun 1997 A
5643197 Brucker et al. Jul 1997 A
5653692 Masterson et al. Aug 1997 A
5656029 Imran et al. Aug 1997 A
5658278 Imran et al. Aug 1997 A
5671747 Connor Sep 1997 A
5673695 McGee et al. Oct 1997 A
5673704 Marchlinski et al. Oct 1997 A
5676662 Fleischhacker et al. Oct 1997 A
5676692 Sanghvi et al. Oct 1997 A
5676693 LaFontaine Oct 1997 A
5678550 Bassen et al. Oct 1997 A
5680860 Imran Oct 1997 A
5681278 Igo et al. Oct 1997 A
5681308 Edwards et al. Oct 1997 A
5687723 Avitall Nov 1997 A
5687737 Branham et al. Nov 1997 A
5688267 Panescu et al. Nov 1997 A
5690611 Swartz et al. Nov 1997 A
5697281 Eggers et al. Dec 1997 A
5697536 Eggers et al. Dec 1997 A
5697882 Eggers et al. Dec 1997 A
5697909 Eggers et al. Dec 1997 A
5697925 Taylor Dec 1997 A
5697927 Imran et al. Dec 1997 A
5697928 Walcott et al. Dec 1997 A
5713942 Stern et al. Feb 1998 A
5716389 Walinsky et al. Feb 1998 A
5718241 Ben-Haim et al. Feb 1998 A
5718701 Shai et al. Feb 1998 A
5720775 Larnard Feb 1998 A
5722402 Swanson et al. Mar 1998 A
5725524 Mulier et al. Mar 1998 A
5730074 Peter Mar 1998 A
5730127 Avitall Mar 1998 A
5730704 Avitall Mar 1998 A
5733280 Avitall Mar 1998 A
5733281 Nardella Mar 1998 A
5735280 Sherman et al. Apr 1998 A
5735290 Sterman et al. Apr 1998 A
5749869 Lindenmeier et al. May 1998 A
5755760 Maguire et al. May 1998 A
5769846 Edwards et al. Jun 1998 A
5782828 Chen et al. Jul 1998 A
5785706 Bednarek Jul 1998 A
5788636 Curley Aug 1998 A
5792140 Tu et al. Aug 1998 A
5797960 Stevens et al. Aug 1998 A
5800428 Nelson et al. Sep 1998 A
5800482 Pemeranz et al. Sep 1998 A
5807395 Mulier et al. Sep 1998 A
5810802 Panescu et al. Sep 1998 A
5827216 Igo et al. Oct 1998 A
5836947 Fleischman et al. Nov 1998 A
5840030 Ferek-Petric et al. Nov 1998 A
5844349 Oakley et al. Dec 1998 A
5846187 Wells et al. Dec 1998 A
5846191 Wells et al. Dec 1998 A
5849028 Chen Dec 1998 A
5860951 Eggers et al. Jan 1999 A
5868739 Lindènmeier et al. Feb 1999 A
5871523 Fleischman et al. Feb 1999 A
5871525 Edwards et al. Feb 1999 A
5873845 Cline et al. Feb 1999 A
5876357 Tomer Mar 1999 A
5876398 Mulier et al. Mar 1999 A
5876399 Chia et al. Mar 1999 A
5879295 Li et al. Mar 1999 A
5879296 Ockuly et al. Mar 1999 A
5881732 Sung et al. Mar 1999 A
5882346 Pomeranz et al. Mar 1999 A
5885278 Fleischman Mar 1999 A
5888198 Eggers et al. Mar 1999 A
5891095 Eggers et al. Apr 1999 A
5893848 Negus et al. Apr 1999 A
5895417 Pomeranz et al. Apr 1999 A
5897553 Mulier et al. Apr 1999 A
5897554 Chia et al. Apr 1999 A
5899898 Arless et al. May 1999 A
5899899 Arless et al. May 1999 A
5902289 Swartz et al. May 1999 A
5902328 LaFontaine et al. May 1999 A
5904711 Flom et al. May 1999 A
5906580 Kline-Schoder et al. May 1999 A
5906587 Zimmon May 1999 A
5906606 Chee et al. May 1999 A
5906613 Mulier et al. May 1999 A
5908029 Knudson et al. Jun 1999 A
5913854 Maguire et al. Jun 1999 A
5916213 Haissaguerre et al. Jun 1999 A
5916214 Cosio et al. Jun 1999 A
5921924 Avitall Jul 1999 A
5921982 Lesh et al. Jul 1999 A
5927284 Borst et al. Jul 1999 A
5928191 Houser et al. Jul 1999 A
5931810 Grabek Aug 1999 A
5931848 Saadat Aug 1999 A
5954661 Greenspon et al. Sep 1999 A
5971980 Sherman Oct 1999 A
5971983 Lesh Oct 1999 A
5976128 Schilling et al. Nov 1999 A
5993447 Blewett et al. Nov 1999 A
6007499 Martin et al. Dec 1999 A
6012457 Lesh Jan 2000 A
6016811 Knopp et al. Jan 2000 A
6042556 Beach et al. Mar 2000 A
6063081 Mulier May 2000 A
6071279 Whayne et al. Jun 2000 A
6083223 Baker Jul 2000 A
6088894 Oakley Jul 2000 A
6096037 Mulier et al. Aug 2000 A
6113592 Taylor Sep 2000 A
6117101 Diederich et al. Sep 2000 A
6120496 Whayne et al. Sep 2000 A
6142993 Whayne et al. Nov 2000 A
6142994 Swanson et al. Nov 2000 A
6152920 Thompson et al. Nov 2000 A
6161543 Cox et al. Dec 2000 A
6165174 Jacobs et al. Dec 2000 A
6216704 Ingle et al. Apr 2001 B1
6217528 Koblish et al. Apr 2001 B1
6217576 Tu et al. Apr 2001 B1
6224592 Eggers et al. May 2001 B1
6231518 Grabek et al. May 2001 B1
6235024 Tu May 2001 B1
6235027 Herzon May 2001 B1
6237605 Vaska et al. May 2001 B1
6238347 Nix et al. May 2001 B1
6238393 Mulier May 2001 B1
6245061 Panescu et al. Jun 2001 B1
6245064 Lesh et al. Jun 2001 B1
6245065 Panescu et al. Jun 2001 B1
6251092 Qin et al. Jun 2001 B1
6251128 Knopp et al. Jun 2001 B1
6270471 Hechel et al. Aug 2001 B1
6293943 Panescu et al. Sep 2001 B1
6296619 Brisken et al. Oct 2001 B1
6302880 Schaer Oct 2001 B1
6311692 Vaska et al. Nov 2001 B1
6312383 Lizzi et al. Nov 2001 B1
6314962 Vaska et al. Nov 2001 B1
6314963 Vaska et al. Nov 2001 B1
6325797 Stewart et al. Dec 2001 B1
6328736 Mulier Dec 2001 B1
6332881 Carner et al. Dec 2001 B1
6358248 Mulier Mar 2002 B1
6361531 Hissong Mar 2002 B1
6364876 Erb et al. Apr 2002 B1
6368275 Sliwa et al. Apr 2002 B1
6371955 Fuimaono et al. Apr 2002 B1
6383151 Diederich et al. May 2002 B1
6385472 Hall et al. May 2002 B1
6398792 O'Connor Jun 2002 B1
6409722 Hoey Jun 2002 B1
6413254 Hissong et al. Jul 2002 B1
6419648 Vitek et al. Jul 2002 B1
6425867 Vaezy et al. Jul 2002 B1
6430426 Avitall Aug 2002 B2
6440130 Mulier Aug 2002 B1
6443952 Mulier Sep 2002 B1
6447507 Bednarek et al. Sep 2002 B1
6461314 Pant et al. Oct 2002 B1
6461356 Patterson Oct 2002 B1
6464700 Koblish et al. Oct 2002 B1
6471697 Lesh Oct 2002 B1
6471698 Edwards et al. Oct 2002 B1
6474340 Vaska et al. Nov 2002 B1
6475216 Mulier Nov 2002 B2
6477396 Mest et al. Nov 2002 B1
6484727 Vaska et al. Nov 2002 B1
6488680 Francischelli et al. Dec 2002 B1
6502575 Jacobs et al. Jan 2003 B1
6514250 Jahns Feb 2003 B1
6527767 Wang et al. Mar 2003 B2
6537248 Mulier Mar 2003 B2
6537272 Christopherson et al. Mar 2003 B2
6558382 Jahns May 2003 B2
6562037 Paton et al. May 2003 B2
6582451 Marucci et al. Jun 2003 B1
6584360 Francischelli et al. Jun 2003 B2
6585732 Mulier Jul 2003 B2
6605084 Acker et al. Aug 2003 B2
6610055 Swanson et al. Aug 2003 B1
6610060 Mulier Aug 2003 B2
6613048 Mulier Sep 2003 B2
6645199 Jenkins et al. Nov 2003 B1
6648883 Francischelli et al. Nov 2003 B2
6656175 Francischelli Dec 2003 B2
6660001 Gregory Dec 2003 B2
6663627 Francischelli Dec 2003 B2
6692450 Coleman Feb 2004 B1
6699240 Francischelli Mar 2004 B2
6702811 Stewart et al. Mar 2004 B2
6706038 Francischelli et al. Mar 2004 B2
6706039 Mulier Mar 2004 B2
6716211 Mulier Apr 2004 B2
6736810 Hoey May 2004 B2
6755827 Mulier Jun 2004 B2
6764487 Mulier Jul 2004 B2
6773433 Stewart et al. Aug 2004 B2
6776780 Mulier Aug 2004 B2
6807968 Francischelli Oct 2004 B2
6827715 Francischelli Dec 2004 B2
6849073 Hoey Feb 2005 B2
6858028 Mulier Feb 2005 B2
6887238 Jahns May 2005 B2
6899711 Stewart et al. May 2005 B2
6911019 Mulier Jun 2005 B2
6916318 Francischelli Jul 2005 B2
6936046 Hissong Aug 2005 B2
6949097 Stewart et al. Sep 2005 B2
6949098 Mulier Sep 2005 B2
6960205 Jahns Nov 2005 B2
6962589 Mulier Nov 2005 B2
7025764 Paton et al. Apr 2006 B2
7267677 Johnson et al. Sep 2007 B2
20010039417 Harano et al. Nov 2001 A1
20020052599 Goble May 2002 A1
20020091384 Hooven et al. Jul 2002 A1
20020091385 Paton et al. Jul 2002 A1
20020120267 Phan Aug 2002 A1
20030018329 Hooven Jan 2003 A1
20030045872 Jacobs Mar 2003 A1
20030144656 Ocel Jul 2003 A1
20030171745 Francischelli et al. Sep 2003 A1
20030191462 Jacobs Oct 2003 A1
20030195384 Francischelli et al. Oct 2003 A1
20030199869 Johnson et al. Oct 2003 A1
20030216724 Jahns Nov 2003 A1
20040015106 Coleman Jan 2004 A1
20040015219 Francischelli Jan 2004 A1
20040044340 Francischelli Mar 2004 A1
20040049179 Francischelli Mar 2004 A1
20040078069 Francischelli Apr 2004 A1
20040082948 Stewart et al. Apr 2004 A1
20040087940 Jahns May 2004 A1
20040092926 Hoey May 2004 A1
20040138621 Jahns Jul 2004 A1
20040138656 Francischelli Jul 2004 A1
20040143260 Francischelli Jul 2004 A1
20040143263 Schechter et al. Jul 2004 A1
20040186465 Francischelli Sep 2004 A1
20040215183 Hoey Oct 2004 A1
20040220560 Briscoe Nov 2004 A1
20040236322 Mulier Nov 2004 A1
20040267252 Washington et al. Dec 2004 A1
20040267326 Ocel Dec 2004 A1
20050010095 Stewart et al. Jan 2005 A1
20050033278 McClurken et al. Feb 2005 A1
20050033280 Francischelli Feb 2005 A1
20050090815 Francischelli Apr 2005 A1
20050113828 Shields et al. May 2005 A1
20050143729 Francischelli Jun 2005 A1
20050165392 Francischelli Jul 2005 A1
20050209564 Bonner Sep 2005 A1
20050256522 Francischelli et al. Nov 2005 A1
20050267454 Hissong Dec 2005 A1
20060009756 Francischelli Jan 2006 A1
20060009759 Chrisitian Jan 2006 A1
Foreign Referenced Citations (2)
Number Date Country
03-020139 Mar 2003 WO
03-090630 Nov 2003 WO
Related Publications (1)
Number Date Country
20050256522 A1 Nov 2005 US